Chemistry:Birabresib

From HandWiki
Short description: Chemical compound


Birabresib
Birabresib.svg
Legal status
Legal status
  • Investigational
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
Chemical and physical data
FormulaC25H22ClN5O2S
Molar mass491.99 g·mol−1
3D model (JSmol)

Birabresib (OTX-015, MK-8628)[1] is an experimental small molecule inhibitor of BRD2, BRD3, and BRD4 under investigation for the treatment of cancer. It is in development by Merck & Co. It is currently in clinical trials for leukemia and glioblastoma.[2]

References